Guillain-Barré Syndrome After COVID-19 mRNA Vaccination in a Liver Transplantation Recipient With Favorable Treatment Response

Liver Transpl. 2022 Jan;28(1):134-137. doi: 10.1002/lt.26279. Epub 2021 Nov 30.

Authors

Dempsey L Hughes¹, Jenna A Brunn, Jansen Jacobs, Peter K Todd, Fredrick K Askari, Robert J Fontana

Affiliation

¹ Division of Gastroenterology and Hepatology University of Michigan Ann Arbor MI Department of Neurology University of Michigan Ann Arbor MI Department of Internal Medicine University of Michigan Ann Arbor MI.

No abstract available

MeSH terms

COVID-19*
Guillain-Barre Syndrome* / diagnosis
Guillain-Barre Syndrome* / etiology
Humans
Liver Transplantation* / adverse effects
RNA, Messenger
SARS-CoV-2
Vaccination / adverse effects

Substances

RNA, Messenger